2016
DOI: 10.1002/cpsc.15
|View full text |Cite
|
Sign up to set email alerts
|

Comprehensive Protocols for CRISPR/Cas9‐based Gene Editing in Human Pluripotent Stem Cells

Abstract: Application of the CRISPR/Cas9 system to edit the genomes of human pluripotent stem cells (hPSCs) has the potential to revolutionize hPSC-based disease modeling, drug screening, and transplantation therapy. Here, we aim to provide a single resource to enable groups, even those with limited experience with hPSC culture or the CRISPR/Cas9 system, to successfully perform genome editing. The methods are presented in detail and are supported by a theoretical framework to allow for the incorporation of inevitable im… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
40
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
1

Relationship

3
3

Authors

Journals

citations
Cited by 36 publications
(40 citation statements)
references
References 114 publications
(213 reference statements)
0
40
0
Order By: Relevance
“…After cells had reached approximately 70% confluence, we duplicated plates to allow one plate of clones to be frozen down for later use and the other to provide genomic DNA for our sequencing pipeline. This gene editing workflow is described in detail elsewhere (47).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…After cells had reached approximately 70% confluence, we duplicated plates to allow one plate of clones to be frozen down for later use and the other to provide genomic DNA for our sequencing pipeline. This gene editing workflow is described in detail elsewhere (47).…”
Section: Resultsmentioning
confidence: 99%
“…For the production of gRNAs, a 120 nucleotide oligo (Integrated DNA Technologies Inc.) including the SP6 promoter, gRNA sequences, and scaffold region were used as a template for synthesis by in vitro transcription using the MEGAscript SP6 kit (Thermo Fisher, AM1330) as previously described [19]. The resulting sgRNAs were purified using the E.Z.N.A miRNA purification kit (Omega Bio-tek, R7034-01), eluted in RNase-free water, and stored at −80°C.Since gRNAs vay in their efficacy, we designed at least four gRNAs per gene of interest and tested their relative cutting efficiencies in in vitro cleavage assays as previously described (47). We selected the gRNAs that showed activity at the lowest Cas9 concentration at each target gene for transfection in the hPSC cells.…”
Section: Methodsmentioning
confidence: 99%
“…Do not attempt hypothalamic differentiation if there is evidence of cells with a morphology different from that of hPSCs. Eliminate unwanted differentiated cells by aspirating them at each feeding or by manually picking hPSC colonies as described elsewhere (International Stem Cell Initiative Consortium et al, 2010;Ludwig & Thomson, 2007;Santos et al, 2016). b. Wash cells gently and briefly with room temperature DPBS --. c. Add warm EDTA solution to cultures, 1 ml per well in 6-well plate, 5 ml per 10-cm plate.…”
Section: Methodsmentioning
confidence: 99%
“…The presence of spontaneously differentiated cells in hPSC cultures is likely to interfere with efficient hypothalamic differentiation, and the presence of unwanted mutations will complicate downstream analyses. Detailed methods for hPSC culture are provided elsewhere (International Stem Cell Initiative Consortium et al, 2010;Ludwig & Thomson, 2007;Santos et al, 2016).…”
Section: Basic Protocolmentioning
confidence: 99%
See 1 more Smart Citation